Research Article| Volume 4, ISSUE 1, P11-17, July 1992

Determination of the action spectrum for UV-induced plasminogen activator synthesis in mouse keratinocytes in vitro

      This paper is only available as a PDF. To read, Please Download here.


      Mouse epidermal keratinocyte-derived Pam 212 cells were irradiated with UV light, and the culture media were examined for plasminogen activator (PA) activity by measuring the capacity to convert exogenous plasminogen into plasmin. Exposure of cells to a broad spectrum of light in the UVB range induced a significant elevation of PA activity at 16 h after irradiation. A dose-response study revealed that a maximal enhancement, 15-fold higher than non-irradiated controls, was induced at a sublethal UVB dose of 100 J/m2, which significantly inhibited cell proliferation without affecting cell viability. Addition of 5 μg/ml of cycloheximide lowered the UV-induced elevation of PA activity, suggesting that protein synthesis is required for this phenomenon. Action spectra for PA synthesis were obtained by irradiating cells with monochromatic light ranging from 250 to 360 mm, and the data demonstrated that the action spectrum was 250–320 nm in length with a peak between 260 and 280 nm. The results suggest that UV exposure is an important physiological trigger for modulating PA synthesis in the epidermis.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hashimoto K
        • Shafran KM
        • Webber PS
        • Lazarus GS
        • Singer KH
        Anti-cell superface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells: a mechanisms for the loss of epidermal cohesion and blister formation.
        J Exp Med. 1983; 157: 259-272
        • Brown JM
        • Chambers DA
        Effects of biological response modifiers on plasminogen activator activity in epidermal cell culture.
        Br J Dermatol. 1984; 111: 252-256
        • Morioka S
        • Lazarus GS
        • Baird JL
        • Jensen PJ
        Migrating keratinocytes express urokinase-type plasminogen activator.
        J Invest Dermatol. 1987; 88: 418-423
        • Morioka S
        • Lazarus GS
        • Jensen PJ
        Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG.
        J Invest Dermatol. 1987; 89: 474-477
        • Rørth P
        • Nerlov C
        • Blasi F
        • Johnsen M
        Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester.
        Nucleic Acids Res. 1990; 18: 5009-5017
        • Baird J
        • Lazarus GS
        • Belin D
        • Vassalli JD
        • Busso N
        • Gubler P
        • Jensen PJ
        mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis.
        J Invest Dermatol. 1990; 95: 548-552
        • Jensen PJ
        • Baird J
        • Morioka S
        • Lessin S
        • Lazarus GS
        Epidermal plasminogen activator is abnormal in cutaneous lesions.
        J Invest Dermatol. 1988; 90: 777-782
        • Morioka S
        • Jensen PJ
        • Lazarus GS
        Human epidermal plasminogen activator: characterization, localization, and modulation.
        Exp Cell Res. 1985; 161: 364-372
        • Grøndahl-Hansen J
        • Lund LR
        • Ralfkiaer E
        • Ottevanger V
        • Danø K
        Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in-vitro.
        J Invest Dermatol. 1988; 90: 790-795
        • Isseroff RR
        • Fusenig NE
        • Rifkin DB
        Plasminogen activator in differentiating mouse keratinocytes.
        J Invest Dermatol. 1983; 80: 217-222
        • Hashimoto K
        • Wun T-C
        • Baird J
        • Lazarus GS
        • Jensen PJ
        Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor.
        J Invest Dermatol. 1989; 92: 310-315
        • Fraki JE
        • Briggaman RA
        • Lazarus GS
        Univolved skin from psoratic patients develops signs of involved psoriatic skin after being grafted onto nude mice.
        Science. 1982; 215: 685-687
        • Grøndahl-Hansen J
        • Ralfkiaer E
        • Nielsen LS
        • Kristensen P
        • Frentz G
        • Danø K
        Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin.
        J Invest Dermatol. 1987; 88: 28-32
        • Stoppelli MP
        • Verde P
        • Grimaldi G
        • Locatelli EK
        • Blasi F
        Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promotor, phorbol myristate acetate.
        J Cell Biol. 1986; 102: 1235-1241
        • Vitti G
        • Hamilton JA
        Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid.
        Arthritis Rhum. 1988; 31: 1046-1051
        • Michel JB
        • Quertermous T
        Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
        J Immunol. 1989; 143: 890-895
        • Nakagawa J
        • von der Ahe D
        • Pearson D
        • Hemmings BA
        • Shibahara S
        • Nagamine Y
        Transcriptional regulation of a plasminogen activator gene by cyclic AMP in a homologous cell-free system: involvement of cyclic AMP-dependent protein kinase in transcriptional control.
        J Biol Chem. 1988; 263: 2460-2468
        • Griffiths JB
        • Electricwale A
        Amplification of tissue plasminogen activator expression from epithelial cell lines.
        Dev Biol Stand. 1987; 66: 417-422
        • Ichikawa K
        • Takashima A
        • Yasuda S
        • Mizuno N
        UVB enhances tissue plasmin activity of rabbit skin and UVB induces plasminogen activator production by Pam 212 cells.
        Photomed Photobiol. 1988; 10: 181-184
        • Miskin R
        • Reich E
        Plasminogen activator: induction of synthesis by DNA damage.
        Cell. 1980; 19: 217-224
        • Miskin R
        • Ben-Ishai R
        Induction of plasminogen activator by UV light in normal and xeroderma pigmentosum fibroblasts.
        in: 4th edn. Proc Natl Acad Sci, USA. 78. 1981: 6235-6240
        • Ben-Ishai R
        • Sharon R
        • Rothman M
        • Miskin R
        DNA repair and induction of plasminogen activator in human fetal cells treated with ultraviolet light.
        Carcinogenesis. 1984; 5: 357-362
        • Rotem N
        • Axelrod JH
        • Miskin R
        Induction of urokinase-type plasminogen activator by UV light in human fetal fibroblasts is mediated through a UV-induced secreted protein.
        Mol Cell Biol. 1987; 7: 622-631
        • Yuspa Sh
        • Hawley-Nelson P
        • Keohler B
        • Stanley JR
        A survey of transformation markers in differentiating epidermal cell lines in culture.
        Cancer Res. 1980; 40: 4694-4703
        • Kato H
        • Adachi N
        • Ohno Y
        • Iwanaga S
        • Takada K
        • Sakakibara S
        New fluorogenic peptide substrates for plasmin.
        J Biochem. 1980; 88: 183-190
        • Blasi F
        • Vassalli J-D
        • Kano K
        Urokinase-type plasminogen activator: Proenzyme, receptor, and inhibitors.
        J Cell Biol. 1987; 104: 801-804
        • Hashimoto K
        • Prystowsky JH
        • Baird J
        • Lazarus GS
        • Jensen PJ
        Keratinocyte urokinase-type plasminogen activator is secreted as a single chain precursor.
        J Invest Dermatol. 1988; 90: 823-828